News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Maryland
Opinion
When Should Biopharma Companies Buy, Partner or Develop Innovative Assets?
Here’s how to assess whether to develop a new therapy by building a proprietary platform, acquiring another company or asset or partnering with an established entity.
April 24, 2024
·
6 min read
·
Anshul Mangal
PRESS RELEASES
Press Releases
Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
June 2, 2025
·
4 min read
Press Releases
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
June 2, 2025
·
4 min read
Press Releases
Immunocore to present at the 2025 Jefferies Global Healthcare Conference
June 2, 2025
·
1 min read
Press Releases
Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting
May 30, 2025
·
3 min read
Press Releases
Bruker Launches Revolutionary timsOmniTM Mass Spectrometer
May 30, 2025
·
7 min read
Press Releases
Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidence - at Speed, Depth, and Scale
May 30, 2025
·
6 min read
Press Releases
Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis
May 30, 2025
·
6 min read
Press Releases
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
May 30, 2025
·
3 min read
Press Releases
Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting
May 29, 2025
·
3 min read
Press Releases
Novavax to Participate in Upcoming Investor Conferences
May 29, 2025
·
1 min read
Press Releases
Supernus Announces Paragraph IV ANDA Filings for Qelbree®
May 29, 2025
·
4 min read
Press Releases
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference
May 29, 2025
·
4 min read
Press Releases
Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN-01 in Metastatic Pancreatic Cancer
May 28, 2025
·
8 min read
Press Releases
Rapafusyn Selected to Join the Roche Accelerator to Advance Discovery and Development of Transformational Medicines for Difficult-to-Drug Targets Using Non-Degrading Molecular Glues
May 27, 2025
·
1 min read
Press Releases
Avalo Therapeutics to Participate in Upcoming Investor Conferences in June
May 27, 2025
·
1 min read
Press Releases
AbelZeta Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for C-CAR168 for the Treatment of Refractory SLE, Including LN
May 27, 2025
·
3 min read
Press Releases
Sapio Sciences Appoints Gordon McCall as Chief Operating Officer to Drive Global Operational Excellence
May 27, 2025
·
2 min read
Press Releases
IGC Pharma’s Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer’s Market
May 23, 2025
·
4 min read
Press Releases
AbelZeta Presents New Data on C-CAR168 for the Treatment of Autoimmune Diseases at LUPUS 2025
May 23, 2025
·
5 min read
Press Releases
GeneDx to Participate in Upcoming June 2025 Investor Conferences
May 23, 2025
·
1 min read
